...Pierre Loiseau; Aurélie Mailhac; Pierre Duhaut; Reimar W Thomsen Abstract Objective To evaluate whether atherosclerotic cardiovascular disease outcomes, venous thromboembolism, heart failure, and cardiovascular mortality are elevated in patients with primary Sjögren’s syndrome (pSS) compared...

... the original work is properly cited. Chronic coronary syndrome Atrial fibrillation Venous thromboembolism Antithrombotic therapy Long-term, single antiplatelet therapy (SAPT) with aspirin or clopidogrel is the established antithrombotic therapy (AT) regime for patients with chronic coronary syndrome (CCS...

... used to treat and prevent blood clots in patients with atrial fibrillation. Andexanet alfa reverses direct factor Xa inhibitors to help treat various thromboembolic conditions. Although it efficiently reverses anticoagulation by preventing life-threatening bleeding events, the use of andexanet alfa...

.... The risk of alcohol-related pathologies correlates with the patterns of intake and increases with the amount of alcohol consumed. While the effects of alcohol consumption on ischemic stroke and ischemic heart disease are well documented, the impact on venous thromboembolism is less clear. Conflicting...

... is diagnosed in the early postoperative period (within 6 weeks postoperatively) 78.4 Round 3 Abbreviations: CS, Cushing's syndrome; IPSS, inferior petrosal sinus sampling; LMWH, low molecular–weight heparin; VTE, venous thromboembolism. Incident risk factors  Active malignancy or cancer treatment...

... been demonstrated in preventing stroke in atrial fibrillation, managing venous thromboembolism, and offering new options for patients with coronary artery disease and cancer-associated thrombosis. However, challenges remain, including bleeding risks, high costs, and limited efficacy in certain patient...

...) on the impact of AF screening on thromboembolism, major bleeding, and mortality. Methods and results We searched PubMed/MEDLINE and Embase to identify studies providing relevant data through 5 September 2024. Risk ratios (RRs) for each reported outcome of interest were pooled through a meta-analysis...

... approach in clinical practice to manage thrombotic risks effectively. Dedicated prospective studies are needed to validate and integrate these findings into clinical strategies for thromboprophylaxis. adrenal incidentalomas mild autonomous cortisol secretion hypercoagulability venous thromboembolism...

... to fibrinolysis. ^1–4 Changes to coagulation combined with endothelial injury and venous stasis from immobilization, sedation, multiple procedures, and prolonged intensive care unit stay, place burn-injured patients at an increased risk of venous thromboembolism (VTE), which includes deep vein...

... revealed Strongyloides larva in the lumen of duodenal crypts. Stool examination and broncho-alveolar lavage revealed the presence of S. stercoralis larva. Computed tomography of pulmonary angiography revealed pulmonary thromboembolism. A long segment thrombus was also noted in the right external...

... thromboembolism. Figure 2. CONSORT diagram of the population of the CARTAGO study. CONSORT: Consolidated Standard of Reporting Trials. Abbreviations: DVT, deep vein thrombosis; ECOG PS, Eastern Cooperative Oncology Group performance status; PE, pulmonary embolism; VTE, venous thromboembolism. The median age...

... Background Venous thromboembolism (VTE) is a term including deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE is potentially a fatal disease because of its high morbidity and mortality in outpatients and inpatients, especially in hospitalized patients. Therefore, timely and accurate diagnosis...

... to allow for post discharge prophylaxis. subclinical venous thromboembolism pulmonary Resection lung cancer QJM: An International Journal of Medicine, 2024, Vol. 117, Suppl. 2 | ii67 analysis as Risk factors for occurrence of arrhythmias. The multivariate logistic regression analysis shows that the most...

...Søren Riis Petersen; Kasper Bonnesen; Erik Lerkevang Grove; Lars Pedersen; Morten Schmidt Abstract Background and Aims The bleeding risk of using non-steroidal anti-inflammatory drugs (NSAIDs) in patients treated with oral anticoagulants for venous thromboembolism (VTE) remains unclear...

... Publication Model ( https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) Abstract Background Recent studies of children with inflammatory bowel disease (IBD) demonstrate an increased venous thromboembolism (VTE) risk. However, estimates of risk are variable and case numbers are limited...

... events (MACE) and venous thromboembolism (VTE). This study evaluates the MACE and VTE risks in IBD patients treated with biologics or OSM. Methods Using the TrinNetX multi-institutional database, we examined MACE and VTE in adult IBD patients on biologics and compared them to IBD patients...

... traps (NETs) are promising promoters in venous thromboembolism (VTE). In the present study, we have investigated the potential thrombogenic role of NETs in colorectal cancer (CRC). A total of 583 patients with gastrointestinal malignancies who were diagnosed with or without VTE by extremities...

... for venous thromboembolism (VTE). Few studies have evaluated the effectiveness of COVID-19 vaccination in preventing hospitalization for COVID-19 with VTE. Methods Adults hospitalized at 21 sites between March 2021 and October 2022 with symptoms of acute respiratory illness were assessed for COVID-19...

... beneficial effects for patients following venous thromboembolism (VTE), with the most significant reductions in risk appearing over time, particularly beyond the first year of treatment. However, there is a lack of randomized controlled data supporting their efficacy and safety in conjunction with standard...

...%) 511 616 (87.6%) Follow-up time 15.9 ± 12.5 16.9 ± 12.5 <0.001 VTE event 554 (0.8%) 1571 (0.3%) <0.001 DVT event 241 (0.4%) 1045 (0.2%) <0.001 PE event 162 (0.2%) 452 (0.1%) <0.001 Other thromboembolic event 234 (0.3%) 348 (0.1%) <0.001 Lesion group 1...